Drug intelligence / Profile preview

Aspergillus fumigatus extract

Development stage
Preclinical
Lead developer
Bayer
Modality
Sublingual Immunotherapy → Allergy Immunotherapy → Therapeutic Vaccines → Vaccines & Immunotherapeutics, Subcutaneous Immunotherapy → Allergy Immunotherapy → Therapeutic Vaccines → Vaccines & Immunotherapeutics, Recombinant Proteins and Enzymes
Administration
Intranasal, Subcutaneous, Intradermal
01

Overview

Aspergillus fumigatus (Af) extract is a research tool consisting of a mixture of culture filtrate and mycelial extracts from the Aspergillus fumigatus fungus. It serves as a naturally occurring airway allergen used in animal models to induce allergic airway inflammation, eosinophilia, and bronchial hyperreactivity (BHR), thereby creating a model for asthma pathophysiology. [1, 2, 4] Intranasal administration in mice is a common method to study the mechanisms of asthma, and research using this extract has shown that the resulting allergic inflammation can be mediated by both IgE-dependent and IgE-independent pathways.

Other names
Aspergillus fumigatus extractAf extractAspergillus antigen
02

Targets

A. annua-specific IgE (Artemisia annua-specific immunoglobulin E)

Beyond the preview

Go deeper on Aspergillus fumigatus extract.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Full profile access

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Full profile access

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Full profile access

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Full profile access

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Full profile access

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Aspergillus fumigatus extract.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call